Ducommun Incorporated
NYSE:DCOAerospace & Defense
-$0.37 today
- Market cap
- $2.13B
- Beta
- 1.07
- P/E (TTM)
- -75.1
- EPS (TTM)
- -$2.17
Volume 0.18M
Average 0.21M
DCO EBITDA
Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.
Ducommun IncorporatedNYSE: DCO
EBITDA · Q2 FY2026 · quarter ended Jul 2026
EBITDA growth accelerates
Q2 FY2026 EBITDA of $36.89M rose 35.7% year over year, ahead of the -93.8% change in trailing-twelve-month EBITDA. Sequentially, it rose 131.4% from the prior quarter.
Context
- EBITDA amounted to 0.1% of revenue in FY2025, down 10.8 pp from a year earlier.
- EBITDA increased in 1 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether EBITDA reaches the consensus estimate from 3 analysts of $123.68M (+13646.8%) for the fiscal year ending Dec 2026, a step up from the -101.1% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterJul 2026
- $36.89M+131.4% QoQ
- Last fiscal yearDec 2025
- -$913K-101.1% YoY
- LTMJul 2026
- $5.87M-93.8% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +35.7% | +145.0% | +109.4 pp |
| 1 year | -101.1% | +13646.8% | +13747.8 pp |
| 3-year CAGR | — | — | — |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA history
USD · from the income statement
- Latest · FY2025
- (913K) USD
- Year-over-year change
- -101.1%
| Period | Period end | EBITDA | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (913K) | -101.1% |
| FY2024 | 2024-12-31 | 85.65M | +22.8% |
| FY2023 | 2023-12-31 | 69.72M | -8.6% |
| FY2022 | 2022-12-31 | 76.31M | -63.7% |
| FY2021 | 2021-12-31 | 210.06M | — |
EBITDA vs competitors
How DCO compares with its peers on the latest reported figures
- Peers report in different currencies, so EBITDA is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of -93.8% is the lowest of 10, against a peer median of +2.6%.
- EBITDA amounts to 0.7% of revenue for DCO, versus a peer median of 17.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Dec 2024 | CN¥1.22B CNY | +25.4% | +19.8% | 6.4% | |
| LTM Mar 2026 | $578.4M USD | +2.6% | -8.4% | 68.1% | |
| LTM Apr 2026 | $181.6M USD | +8.0% | -10.9% | 20.3% | |
| LTM Mar 2026 | $87.01M USD | +5.6% | +43.9% | 13.7% | |
| LTM Apr 2026 | $64.86M USD | +27.2% | +78.3% | 9.5% | |
| LTM Mar 2026 | $45.38M USD | -16.1% | +29.9% | 23.0% | |
| LTM Mar 2026 | $30.36M USD | -85.1% | -41.7% | 1.6% | |
| LTM Jul 2026 | $5.87M USD | -93.8% | — | 0.7% | |
| LTM Jun 2026 | -$170.96M USD | -81.3% | — | 40.1% | |
EVEXEve Holding, Inc. | LTM Mar 2026 | -$228.86M USD | -46.2% | — | — |
| Peer median (excluding DCO) | — | +2.6% | +19.8% | 17.0% | |
Competitors are the stored peer set for DCO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 645.41M | 712.54M | 756.99M | 786.55M | 824.84M |
| Cost of Revenue | 502.95M | 568.24M | 593.81M | 589.29M | 603.22M |
| Gross Profit | 142.46M | 144.3M | 163.19M | 197.27M | 221.62M |
| Gross Margin | 22.1% | 20.3% | 21.6% | 25.1% | 26.9% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 93.58M | 98.35M | 119.73M | 138.61M | 147.81M |
| Operating Expenses | 93.58M | 104.51M | 134.27M | 145.05M | 147.81M |
| Depreciation & Amortization | 28.39M | 31.42M | 32.57M | 33.44M | 33.66M |
| EBITDA | 210.06M | 76.31M | 69.72M | 85.65M | (913K) |
| EBITDA Margin | 32.5% | 10.7% | 9.2% | 10.9% | -0.1% |
| Operating Income | 48.88M | 39.79M | 28.92M | 52.21M | 73.81M |
| Operating Margin | 7.6% | 5.6% | 3.8% | 6.6% | 8.9% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 11.19M | 11.57M | 20.77M | 15.3M | 12.68M |
| Other Income / Expenses | 121.6M | (6.47M) | (12.54M) | (15.3M) | (121.05M) |
| Income Before Tax | 170.48M | 33.32M | 16.38M | 36.91M | (47.25M) |
| Pre-Tax Margin | 26.4% | 4.7% | 2.2% | 4.7% | -5.7% |
| Income Tax Expense | 34.95M | 4.53M | 451K | 5.41M | (9.89M) |
| Net Income | 135.54M | 28.79M | 15.93M | 31.5M | (37.35M) |
| Net Margin | 21.0% | 4.0% | 2.1% | 4.0% | -4.5% |
| EPS (Basic) | 11.41 | 2.38 | 1.16 | 2.13 | (2.50) |
| EPS (Diluted) | 11.06 | 2.33 | 1.14 | 2.10 | (2.50) |
| Weighted Avg Shares | 11.88M | 12.07M | 13.72M | 14.77M | 14.94M |
| Weighted Avg Shares (Diluted) | 12.25M | 12.37M | 13.97M | 15.01M | 14.94M |
Ducommun Incorporated
NYSE:DCO
Intrinsic Alpha fair value
Locked
Current Price
$140.83
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.